Geopolitical uncertainties, pricing pressure in core portfolio in the U.S., higher R&D expenses likely to drag revenue up to 20%, profit 30% in current fiscal
Business
Natco Pharma logs highest-ever sales, net in FY25, wary of headwinds for U.S. business in FY26
by aweeincm1
Recent Post
Chief Of Defence Staff On “Multi-Domain” Op Sindoor, AI’s Role In Warfare
Operation Sindoor was a non-contact, multi-domain mission which included aspects ... Read more
India’s Covid Cases Rise To 2,710, Kerala, Maharashtra, Delhi Worst Hit
According to the data by Ministry of Health and Family ... Read more
Operation Shield: Security Drills In States Neighbouring Pakistan Today
In a significant move to enhance national security preparedness, civil ... Read more
US Border Officials Arrest Illegal Indian Immigrant On Child Predator Charges
Border authorities have arrested an Indian citizen living illegally in ... Read more